Skip to main content

Advertisement

Table 1 The association of clinicopathological factors with miR-591 expression in 78 breast cancer patients

From: MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway

Characteristics Total MiR-591 expression level P-value
Lower (n = 38) Higher (n = 40)
Age (years) 0.267
≤ 45 32 18 14  
> 45 46 20 26  
Tumor size (cm) 0.519
< 2 30 16 14  
> 2 48 22 26  
PR status 0.223
No 30 12 18  
Yes 48 26 22  
TNM stage 0.011*
I/II 50 19 31  
III 28 19 9  
Lymph node metastasis 0.005*
No 53 20 33  
Yes 25 18 7  
Bone metastasis 0.615
No 70 34 36  
Yes 8 4 4  
ER     0.972
No 45 22 23  
Yes 33 16 17  
Histological grade 0.262
G1/2 52 23 29  
G3 26 15 11  
  1. ER estrogen receptor, PR progesterone receptor
  2. * P < 0.05